Central de misturas intravenosas em neonatologia: um estudo baseado em uma maternidade escola
Objectives: To analyze the economic feasibility of implementing an intravenous mixing center (IVCM) in a Maternity Hospital applied to a neonatal intensive care unit (NICU). Methods: Cross-sectional, retrospective and analytical study with a quantitative approach. The study sample included prescript...
Na minha lista:
| Autor principal: | |
|---|---|
| Outros Autores: | |
| Formato: | bachelorThesis |
| Idioma: | pt_BR |
| Publicado em: |
Universidade Federal do Rio Grande do Norte
|
| Assuntos: | |
| Endereço do item: | https://repositorio.ufrn.br/handle/123456789/45727 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|
| Resumo: | Objectives: To analyze the economic feasibility of implementing an intravenous mixing center (IVCM) in a Maternity Hospital applied to a neonatal intensive care unit (NICU). Methods: Cross-sectional, retrospective and analytical study with a quantitative approach. The study sample included prescriptions for newborns hospitalized in the Neonatal Intensive Care Unit, from 01/01/2018 to 12/31/2018, of both genders, as an inclusion criterion to have at least one injectable drug prescribed. Data collection was performed using medical prescriptions issued by the Management Application for University Hospitals. Results: The results were favorable from a pharmacoeconomic point of view. The handling of the evaluated injectable drugs would generate savings of 39.00%, corresponding to an amount of R$ 56,695.66 per year, when compared to the current distribution model. Regarding infusion pumps, an analysis was performed with the four most used presentations in continuous infusion pump (BIC) in the NICU, which were: Dobutamine 12.5 mg/mL (20mL), Dopamine 5 mg/mL (10mL) ), Fentanyl 50 mcg/ml (10ml) and Midazolam 5mg/ml (10ml). The total amount dispensed for these drugs in the current model was R$6,406.95, while with the simulation of a CMIV, there would be savings of 35.04% equivalent to R$2,245.01, even if administered via BIC. Considering the administration by syringe pump (BS), the savings would be even greater than 51.83%, which corresponds to R$ 3,321.2 of the R$ 6,406.95. Conclusion: Therefore, the implementation of an Intravenous Mixing Center proved to be a promising and economically viable alternative. |
|---|